0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pleuromutilin Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-28W14156
Home | Market Reports | Health| Pharmacy
Global Pleuromutilin Market Research Report 2023
BUY CHAPTERS

Global Pleuromutilin Market Research Report 2025

Code: QYRE-Auto-28W14156
Report
March 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pleuromutilin Market Size

The global market for Pleuromutilin was valued at US$ 90.4 million in the year 2024 and is projected to reach a revised size of US$ 126 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Pleuromutilin Market

Pleuromutilin Market

Pleuromutilin is a broad-spectrum diterpene antibiotic produced by Pleurotus mutilus. It is the precursor of semi-synthetic derivatives of pleuromutilin and can effectively inhibit most Gram-negative bacteria. positive bacteria and some Gram-negative bacteria.
Pleuromutilin is a class of antibacterial substances that work by inhibiting the synthesis of protein in bacteria. Pleuromutilins were discovered in the 1950s mainly for veterinary purposes. Pleuromutilin is used for the treatment and prevention of gastrointestinal and respiratory infections caused by different bacterial pathogens in pigs, poultry and rabbits.
In our report, our statistical standard is based on 100% content. Active Ingredient Contents is 100%.
Global key players of Pleuromutilin include Sunny Biotech, Hebei Weiyuan, Shandong Shengli, Shandong Lukang, etc. Global top four manufacturers hold a share over 55%.
Asia-Pacific is the largest market of Pleuromutilin, holds a share over 90%, followed by Asia-Pacific, North America.
In terms of application, the largest application is Livestock, with a share around 90%, followed by Poultry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pleuromutilin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pleuromutilin.
The Pleuromutilin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pleuromutilin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pleuromutilin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pleuromutilin Market Report

Report Metric Details
Report Name Pleuromutilin Market
Accounted market size in year US$ 90.4 million
Forecasted market size in 2031 US$ 126 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Livestock
  • Poultry
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sunny Biotech, Hebei Weiyuan, Shandong Shengli, Shandong Lukang, Qingdao Dierman, Qilu Pharma, Huvepharma, Novartis, Vethellas, Elanco
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pleuromutilin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pleuromutilin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pleuromutilin Market growing?

Ans: The Pleuromutilin Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Pleuromutilin Market size in 2031?

Ans: The Pleuromutilin Market size in 2031 will be US$ 126 million.

What is the market share of major companies in Pleuromutilin Market?

Ans: Global top four manufacturers hold a share over 55%.

Who are the main players in the Pleuromutilin Market report?

Ans: The main players in the Pleuromutilin Market are Sunny Biotech, Hebei Weiyuan, Shandong Shengli, Shandong Lukang, Qingdao Dierman, Qilu Pharma, Huvepharma, Novartis, Vethellas, Elanco

What are the Application segmentation covered in the Pleuromutilin Market report?

Ans: The Applications covered in the Pleuromutilin Market report are Livestock, Poultry

What are the Type segmentation covered in the Pleuromutilin Market report?

Ans: The Types covered in the Pleuromutilin Market report are Premix, API Powder

Recommended Reports

Animal Health

Respiratory Diseases

Anti Infectives

1 Pleuromutilin Market Overview
1.1 Product Definition
1.2 Pleuromutilin by Type
1.2.1 Global Pleuromutilin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Premix
1.2.3 API Powder
1.3 Pleuromutilin by Application
1.3.1 Global Pleuromutilin Market Value by Application (2024 VS 2031)
1.3.2 Livestock
1.3.3 Poultry
1.4 Global Pleuromutilin Market Size Estimates and Forecasts
1.4.1 Global Pleuromutilin Revenue 2020-2031
1.4.2 Global Pleuromutilin Sales 2020-2031
1.4.3 Global Pleuromutilin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pleuromutilin Market Competition by Manufacturers
2.1 Global Pleuromutilin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pleuromutilin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pleuromutilin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pleuromutilin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pleuromutilin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pleuromutilin, Product Type & Application
2.7 Global Key Manufacturers of Pleuromutilin, Date of Enter into This Industry
2.8 Global Pleuromutilin Market Competitive Situation and Trends
2.8.1 Global Pleuromutilin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pleuromutilin Players Market Share by Revenue
2.8.3 Global Pleuromutilin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pleuromutilin Market Scenario by Region
3.1 Global Pleuromutilin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pleuromutilin Sales by Region: 2020-2031
3.2.1 Global Pleuromutilin Sales by Region: 2020-2025
3.2.2 Global Pleuromutilin Sales by Region: 2026-2031
3.3 Global Pleuromutilin Revenue by Region: 2020-2031
3.3.1 Global Pleuromutilin Revenue by Region: 2020-2025
3.3.2 Global Pleuromutilin Revenue by Region: 2026-2031
3.4 North America Pleuromutilin Market Facts & Figures by Country
3.4.1 North America Pleuromutilin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pleuromutilin Sales by Country (2020-2031)
3.4.3 North America Pleuromutilin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 United States
3.4.6 Canada
3.5 Europe Pleuromutilin Market Facts & Figures by Country
3.5.1 Europe Pleuromutilin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pleuromutilin Sales by Country (2020-2031)
3.5.3 Europe Pleuromutilin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 Poland
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.5.9 Rest of Europe
3.6 Asia Pacific Pleuromutilin Market Facts & Figures by Region
3.6.1 Asia Pacific Pleuromutilin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pleuromutilin Sales by Region (2020-2031)
3.6.3 Asia Pacific Pleuromutilin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pleuromutilin Market Facts & Figures by Country
3.7.1 Latin America Pleuromutilin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pleuromutilin Sales by Country (2020-2031)
3.7.3 Latin America Pleuromutilin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pleuromutilin Market Facts & Figures by Country
3.8.1 Middle East and Africa Pleuromutilin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pleuromutilin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pleuromutilin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pleuromutilin Sales by Type (2020-2031)
4.1.1 Global Pleuromutilin Sales by Type (2020-2025)
4.1.2 Global Pleuromutilin Sales by Type (2026-2031)
4.1.3 Global Pleuromutilin Sales Market Share by Type (2020-2031)
4.2 Global Pleuromutilin Revenue by Type (2020-2031)
4.2.1 Global Pleuromutilin Revenue by Type (2020-2025)
4.2.2 Global Pleuromutilin Revenue by Type (2026-2031)
4.2.3 Global Pleuromutilin Revenue Market Share by Type (2020-2031)
4.3 Global Pleuromutilin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pleuromutilin Sales by Application (2020-2031)
5.1.1 Global Pleuromutilin Sales by Application (2020-2025)
5.1.2 Global Pleuromutilin Sales by Application (2026-2031)
5.1.3 Global Pleuromutilin Sales Market Share by Application (2020-2031)
5.2 Global Pleuromutilin Revenue by Application (2020-2031)
5.2.1 Global Pleuromutilin Revenue by Application (2020-2025)
5.2.2 Global Pleuromutilin Revenue by Application (2026-2031)
5.2.3 Global Pleuromutilin Revenue Market Share by Application (2020-2031)
5.3 Global Pleuromutilin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sunny Biotech
6.1.1 Sunny Biotech Company Information
6.1.2 Sunny Biotech Description and Business Overview
6.1.3 Sunny Biotech Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sunny Biotech Pleuromutilin Product Portfolio
6.1.5 Sunny Biotech Recent Developments/Updates
6.2 Hebei Weiyuan
6.2.1 Hebei Weiyuan Company Information
6.2.2 Hebei Weiyuan Description and Business Overview
6.2.3 Hebei Weiyuan Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hebei Weiyuan Pleuromutilin Product Portfolio
6.2.5 Hebei Weiyuan Recent Developments/Updates
6.3 Shandong Shengli
6.3.1 Shandong Shengli Company Information
6.3.2 Shandong Shengli Description and Business Overview
6.3.3 Shandong Shengli Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shandong Shengli Pleuromutilin Product Portfolio
6.3.5 Shandong Shengli Recent Developments/Updates
6.4 Shandong Lukang
6.4.1 Shandong Lukang Company Information
6.4.2 Shandong Lukang Description and Business Overview
6.4.3 Shandong Lukang Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shandong Lukang Pleuromutilin Product Portfolio
6.4.5 Shandong Lukang Recent Developments/Updates
6.5 Qingdao Dierman
6.5.1 Qingdao Dierman Company Information
6.5.2 Qingdao Dierman Description and Business Overview
6.5.3 Qingdao Dierman Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Qingdao Dierman Pleuromutilin Product Portfolio
6.5.5 Qingdao Dierman Recent Developments/Updates
6.6 Qilu Pharma
6.6.1 Qilu Pharma Company Information
6.6.2 Qilu Pharma Description and Business Overview
6.6.3 Qilu Pharma Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Qilu Pharma Pleuromutilin Product Portfolio
6.6.5 Qilu Pharma Recent Developments/Updates
6.7 Huvepharma
6.7.1 Huvepharma Company Information
6.7.2 Huvepharma Description and Business Overview
6.7.3 Huvepharma Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Huvepharma Pleuromutilin Product Portfolio
6.7.5 Huvepharma Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Company Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novartis Pleuromutilin Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Vethellas
6.9.1 Vethellas Company Information
6.9.2 Vethellas Description and Business Overview
6.9.3 Vethellas Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Vethellas Pleuromutilin Product Portfolio
6.9.5 Vethellas Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Company Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Pleuromutilin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Elanco Pleuromutilin Product Portfolio
6.10.5 Elanco Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pleuromutilin Industry Chain Analysis
7.2 Pleuromutilin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pleuromutilin Production Mode & Process Analysis
7.4 Pleuromutilin Sales and Marketing
7.4.1 Pleuromutilin Sales Channels
7.4.2 Pleuromutilin Distributors
7.5 Pleuromutilin Customer Analysis
8 Pleuromutilin Market Dynamics
8.1 Pleuromutilin Industry Trends
8.2 Pleuromutilin Market Drivers
8.3 Pleuromutilin Market Challenges
8.4 Pleuromutilin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pleuromutilin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pleuromutilin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pleuromutilin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pleuromutilin Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Pleuromutilin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pleuromutilin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pleuromutilin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pleuromutilin Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pleuromutilin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pleuromutilin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pleuromutilin, Product Type & Application
 Table 12. Global Key Manufacturers of Pleuromutilin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pleuromutilin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pleuromutilin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pleuromutilin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pleuromutilin Sales by Region (2020-2025) & (MT)
 Table 18. Global Pleuromutilin Sales Market Share by Region (2020-2025)
 Table 19. Global Pleuromutilin Sales by Region (2026-2031) & (MT)
 Table 20. Global Pleuromutilin Sales Market Share by Region (2026-2031)
 Table 21. Global Pleuromutilin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pleuromutilin Revenue Market Share by Region (2020-2025)
 Table 23. Global Pleuromutilin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pleuromutilin Revenue Market Share by Region (2026-2031)
 Table 25. North America Pleuromutilin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pleuromutilin Sales by Country (2020-2025) & (MT)
 Table 27. North America Pleuromutilin Sales by Country (2026-2031) & (MT)
 Table 28. North America Pleuromutilin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pleuromutilin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pleuromutilin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pleuromutilin Sales by Country (2020-2025) & (MT)
 Table 32. Europe Pleuromutilin Sales by Country (2026-2031) & (MT)
 Table 33. Europe Pleuromutilin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pleuromutilin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pleuromutilin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pleuromutilin Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Pleuromutilin Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Pleuromutilin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pleuromutilin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pleuromutilin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pleuromutilin Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Pleuromutilin Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Pleuromutilin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pleuromutilin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pleuromutilin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pleuromutilin Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Pleuromutilin Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Pleuromutilin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pleuromutilin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pleuromutilin Sales (MT) by Type (2020-2025)
 Table 51. Global Pleuromutilin Sales (MT) by Type (2026-2031)
 Table 52. Global Pleuromutilin Sales Market Share by Type (2020-2025)
 Table 53. Global Pleuromutilin Sales Market Share by Type (2026-2031)
 Table 54. Global Pleuromutilin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pleuromutilin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pleuromutilin Revenue Market Share by Type (2020-2025)
 Table 57. Global Pleuromutilin Revenue Market Share by Type (2026-2031)
 Table 58. Global Pleuromutilin Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Pleuromutilin Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Pleuromutilin Sales (MT) by Application (2020-2025)
 Table 61. Global Pleuromutilin Sales (MT) by Application (2026-2031)
 Table 62. Global Pleuromutilin Sales Market Share by Application (2020-2025)
 Table 63. Global Pleuromutilin Sales Market Share by Application (2026-2031)
 Table 64. Global Pleuromutilin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pleuromutilin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pleuromutilin Revenue Market Share by Application (2020-2025)
 Table 67. Global Pleuromutilin Revenue Market Share by Application (2026-2031)
 Table 68. Global Pleuromutilin Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Pleuromutilin Price (US$/Kg) by Application (2026-2031)
 Table 70. Sunny Biotech Company Information
 Table 71. Sunny Biotech Description and Business Overview
 Table 72. Sunny Biotech Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Sunny Biotech Pleuromutilin Product
 Table 74. Sunny Biotech Recent Developments/Updates
 Table 75. Hebei Weiyuan Company Information
 Table 76. Hebei Weiyuan Description and Business Overview
 Table 77. Hebei Weiyuan Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Hebei Weiyuan Pleuromutilin Product
 Table 79. Hebei Weiyuan Recent Developments/Updates
 Table 80. Shandong Shengli Company Information
 Table 81. Shandong Shengli Description and Business Overview
 Table 82. Shandong Shengli Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Shandong Shengli Pleuromutilin Product
 Table 84. Shandong Shengli Recent Developments/Updates
 Table 85. Shandong Lukang Company Information
 Table 86. Shandong Lukang Description and Business Overview
 Table 87. Shandong Lukang Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Shandong Lukang Pleuromutilin Product
 Table 89. Shandong Lukang Recent Developments/Updates
 Table 90. Qingdao Dierman Company Information
 Table 91. Qingdao Dierman Description and Business Overview
 Table 92. Qingdao Dierman Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Qingdao Dierman Pleuromutilin Product
 Table 94. Qingdao Dierman Recent Developments/Updates
 Table 95. Qilu Pharma Company Information
 Table 96. Qilu Pharma Description and Business Overview
 Table 97. Qilu Pharma Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Qilu Pharma Pleuromutilin Product
 Table 99. Qilu Pharma Recent Developments/Updates
 Table 100. Huvepharma Company Information
 Table 101. Huvepharma Description and Business Overview
 Table 102. Huvepharma Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Huvepharma Pleuromutilin Product
 Table 104. Huvepharma Recent Developments/Updates
 Table 105. Novartis Company Information
 Table 106. Novartis Description and Business Overview
 Table 107. Novartis Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Novartis Pleuromutilin Product
 Table 109. Novartis Recent Developments/Updates
 Table 110. Vethellas Company Information
 Table 111. Vethellas Description and Business Overview
 Table 112. Vethellas Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Vethellas Pleuromutilin Product
 Table 114. Vethellas Recent Developments/Updates
 Table 115. Elanco Company Information
 Table 116. Elanco Description and Business Overview
 Table 117. Elanco Pleuromutilin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Elanco Pleuromutilin Product
 Table 119. Elanco Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Pleuromutilin Distributors List
 Table 123. Pleuromutilin Customers List
 Table 124. Pleuromutilin Market Trends
 Table 125. Pleuromutilin Market Drivers
 Table 126. Pleuromutilin Market Challenges
 Table 127. Pleuromutilin Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pleuromutilin
 Figure 2. Global Pleuromutilin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pleuromutilin Market Share by Type: 2024 & 2031
 Figure 4. Premix Product Picture
 Figure 5. API Powder Product Picture
 Figure 6. Global Pleuromutilin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pleuromutilin Market Share by Application: 2024 & 2031
 Figure 8. Livestock
 Figure 9. Poultry
 Figure 10. Global Pleuromutilin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pleuromutilin Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pleuromutilin Sales (2020-2031) & (MT)
 Figure 13. Global Pleuromutilin Average Price (US$/Kg) & (2020-2031)
 Figure 14. Pleuromutilin Report Years Considered
 Figure 15. Pleuromutilin Sales Share by Manufacturers in 2024
 Figure 16. Global Pleuromutilin Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pleuromutilin Players: Market Share by Revenue in Pleuromutilin in 2024
 Figure 18. Pleuromutilin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pleuromutilin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pleuromutilin Sales Market Share by Country (2020-2031)
 Figure 21. North America Pleuromutilin Revenue Market Share by Country (2020-2031)
 Figure 22. United States Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. United States Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Pleuromutilin Sales Market Share by Country (2020-2031)
 Figure 26. Europe Pleuromutilin Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Poland Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. UK Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Rest of Europe Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Pleuromutilin Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Pleuromutilin Revenue Market Share by Region (2020-2031)
 Figure 35. China Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Pleuromutilin Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Pleuromutilin Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Pleuromutilin Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Pleuromutilin Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Pleuromutilin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Pleuromutilin by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Pleuromutilin by Type (2020-2031)
 Figure 54. Global Pleuromutilin Price (US$/Kg) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Pleuromutilin by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Pleuromutilin by Application (2020-2031)
 Figure 57. Global Pleuromutilin Price (US$/Kg) by Application (2020-2031)
 Figure 58. Pleuromutilin Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart